Lack of expression of c-KIT in ovarian cancers is associated with poor prognosis

International Journal of Cancer

Volumn 89, Issue 3, 2000, Pages 242-250

  Tonary, Angela M ^a,c   Macdonald, Elizabeth A ^c   Faught, Wylam ^b   Senterman, Mary K ^a,b   Vanderhyden, Barbara C ^a,c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c OTTAWA REGIONAL CANCER CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

STEM CELL FACTOR RECEPTOR; TYROSINE KINASE RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CANCER SURVIVAL; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; PROTO ONCOGENE;

BLOTTING, NORTHERN; BLOTTING, WESTERN; CELLS, CULTURED; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; OVARY; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-KIT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0033945084     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20000520)89:3<242::AID-IJC6>3.0.CO;2-6     Document Type: Article

References (40)

1. ARBER, D.A., TAMAYO, R. and WEISS, L.M., Paraffin section detection of the c-kit gene product (CD117) in human tissues: value in the diagnosis of mast cell disorders. Hum. Pathol., 29, 498-504 (1998).
2. AUERSPERG, N., EDELSON, M.I., MOK, S.C., JOHNSON, S.W. and HAMILTON, T.C., The biology of ovarian cancer. Semin. Oncol., 25, 281-304 (1998).
3. BELL, D.A. and SCULLY, R.E., Early de nova ovarian carcinoma. A study of fourteen cases. Cancer, 73,1859-1864 (1994).
4. BRIZZI, M.F., PAVAN, M., ZINI, M.G., AVANZI, G.C. and PEGORARO, L., Regulation of c-kit expression in human myeloid cells. Stem Cells, 11(Suppl. 2), 42-48 (1993).
5. CARUANA, G., CAMBARERI, A.C., GONDA, T.J. and ASHMAN, L.K., Transformation of NIH3T3 fibroblasts by the c-kit receptor tyrosine kinase: effect of receptor density and ligand-requirement. Oncogene. 16, 179-190 (1998).
6. CHAMBERS, S.K., KACINSKI, B.M., IVINS, C.M. and CARCANGIU, M.L., Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1. Clin. Cancer Res., 3, 999-1007 (1997).
7. CROSS, M. and DEXTER, T.M., Growth factors in development, transformation, and tumorigenesis. Cell, 64, 271-280 (1991).
8. DABROW, M.B., FRANCESCO, M.R., MCBREARY, F.X. and CARADONNA, S., The effects of platelet-derived growth factor and receptor on normal and neoplastic human ovarian surface epithelium. Gynecol. Oncol., 71, 29-37 (1998).
9. ERNST, S.I., HUBBS, A.E., PRZYGODZKI, R.M., EMORY, T.S., SOBIN, L.H. and O'LEARY, T.J., KIT mutation portends poor prognosis in gastrointestinal stromal/smooth muscle tumors. Lab. Invest., 78, 1633-1636 (1998).
10. FATHALLA, M., Incessant ovulation: a factor in ovarian neoplasm? Lancet, 2, 163 (1971).
11. HIBI, K., TAKAHASHI, T., SEKIDO, Y., UEDA, R., HIDA, T., ARIYOSHI, Y., TAKAGI, H. and TAKAHASHI, T., Coexpression of the stem cell factor and the c-kit genes in small-cell lung cancer. Oncogene, 6, 2291-2296 (1991).
12. HINES, S.J., ORGAN, C., KORNSTEIN, M.J. and KRYSTAL, G.W., Coexpression of the c-kit and stem cell factor genes in breast carcinomas. Cell Growth Differentiation, 6, 769-779 (1995).
13. HORIE, K., FUJITA, J., TAKAKURA, K., KANZAKI, H., SUGINAMI, H., IWAI, M., NAKAYAMA, H. and MORI, T., The expression of c-kit protein in human adult and fetal tissues. Hum. Reprod., 8, 1955-1962 (1993).
14. HUANG, S., LUCA, M., GUTMAN, M., MCCONKEY, D.J., LANGLEY, K.E., LYMAN, S.D. and BAR-ELI, M., Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential. Oncogene, 13, 2339-2347 (1996).
15. INOUE, M., KYO, S., FUJITA, M., ENOMOTO, T. and KONDOH, G., Coexpression of the c-kit receptor and the stem cell factor in gynecological tumors. Cancer Res., 54, 3049-3053 (1994).
16. ISMAIL, R.S., CADA, M. and VANDERHYDEN, B.C., Transforming growth factor-β regulates Kit ligand expression in rat ovarian surface epithelial cells. Oncogene, 18, 4734-4741 (1999).
17. ISMAIL, R.S., DUBÉ, M. and VANDERHYDEN, B.C., Hormonally regulated expression and alternative splicing of kit ligand may regulate Kit-induced inhibition of meiosis in rat oocytes. Devel. Biol., 184, 333-342 (1997).
18. IZQUIERDO, M.A., VAN DER VALK, P., VAN ARK-OTTE, J., RUBIO, G., GERMA-LLUCH, J.R., UEDA, R., SCHEPER, R.J., TAKAHASHI, T. and GIACCONE, G., Differential expression of the c-kit proto-oncogene in germ cell tumours. J. Pathol., 177, 253-258 (1995).
19. KOHLER, M., JANZ, I., WINTZER, H.O., WAGNER, E. and BAUKNECHT, T., The expression of EGF receptors, EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance. Anticancer Res., 9, 1537-1548 (1989).
20. KONDOH, G., HAYASAKA, N., LI, Q., NISHIMUNE, Y. and HAKURA, A., An in vivo model for receptor tyrosine kinase autocrine/paracrine activation: auto-stimulated KIT receptor acts as a tumor promoting factor in papillomavirus-induced tumorigenesis. Oncogene, 10, 341-347 (1995).
21. KRYSTAL, G.W., HINES, S.J. and ORGAN, C.P., Autocrine growth of small cell lung cancer mediated by coexpression of c-kit and stem cell factor. Cancer Res., 56, 370-376 (1996).
22. LAITINEN, M., RUTANEN, E.M. and RITVOS, O., Expression of c-kit ligand messenger ribonucleic acids in human ovaries and regulation of their steady state levels by gonadotropins in cultured granulosa-luteal cells. Endocrinology, 136, 4407-4414 (1995).
23. LAMMIE, A., DROBNJAK, M., GERALD, W., SAAD, A., COTE, R. and CORDONCARDO, C., Expression of c-kit and kit ligand proteins in normal human tissues. J. Histochem. Cytochem., 42, 1417-1425 (1994).
24. LANCASTER, J.M., WOOSTER, R., MANGION, J., PHELAN, C.M. and COCHRAN, C., BRCA2 mutations in primary breast and ovarian cancer. Nature (Genet.), 13, 238-240 (1996).
25. LEV, S., YARDEN, Y. and GIVOL, D., Receptor functions and ligand-dependent transforming potential of a chimeric kit proto-oncogene. Mol. Cell. Biol., 10, 6064-6068 (1990).
26. MAEDA, H., YAMAGATA, A., NISHIKAWA, S., YOSHINAGA, K., KOBAYASHI, S., NISHI, K. and NISHKAWA, S., Requirement of c-kit for development of intestinal pacemaker system. Development, 116, 369-375 (1992).
27. MORRISON-GRAHAM, K. and TAKAHASHI, Y., Steel factor and c-kit receptor: from mutants to a growth factor system. Bioessays, 15, 77-83 (1993).
28. NATALI, P.G., BERLINGIERI, M.T., NICOTRA, M.R., FUSCO A., SANTORO, E., BIGOTTI, A. and VECCHIO, G., Transformation of thyroid epithelium is associated with loss of c-kit receptor. Cancer Res., 55, 1787-1791 (1995).
29. NATALI, P.G., NICOTRA, M.R., SURES, I., MOTTOLESE, M., BOTTI, C. and ULLRICH, A., Breast cancer is associated with loss of the c-kit oncogene product. Int. J. Cancer, 52, 713-717 (1992a).
30. NATALI, P.G., NICOTRA, M.R., WINKLER, A.B., CAVALIERE, R., BIGOTTI, A. and ULLRICH, A., Progression of human cutaneous melanoma is associated with loss of expression of c-kit proto-oncogene receptor. Int. J. Cancer, 52, 197-201 (1992b).
31. NETA, R., OPPENHEIM, J.J., WANG, J.M., SNAPPER, C.M., MOORMAN, M.A. and DUBOIS, C.M., Synergy of IL-1 and stem cell factor in radioprotection of mice is associated with IL-1 up-regulation of mRNA and protein expression for c-kit on bone marrow cells. J. Immunol., 153, 1536-1543 (1994).
32. NISHINA, Y., KOBARAI, Y., SUMI, T., KOSAKA, M., NISHIKAWA, S. and NISHIMUNE, Y., Expression of c-kit protooncogene is stimulated by cAMP in differentiated F9 mouse teratocarcinoma cells. Exp. Cell Res., 198, 352-356 (1992).
33. QUI, F., RAY, P., BROWN, K., BARKER, P.E., JHANWAR, S., RUDDLE, F.H. and BESMER, P., Primary structure of c-kit: relationship with the CSF-1/PDGF receptor kinase family - oncogenic activation of v-kit involves deletion of extracellular domain and c-terminus. EMBO J., 7, 1003-1011 (1988).
34. SAMBROOK, J., FRITSCH, E.F. and MANIATIS, T., Molecular cloning, a laboratory manual (2nd ed.), Cold Spring Harbor, NY (1989).
35. SINCOCK, P.M. and ASHMAN, L.K., Expression of c-Kit and functional drug efflux are correlated in de nova acute myeloid leukaemia. Leukemia, 11, 1850-1857 (1997).
36. STANULLA, M., WELTE, K., HADAM, M.R. and PIETSCH, T., Coexpression of stem cell factor and its receptor c-Kit in human malignant glioma cell lines. Acta Neuropathol., 89, 158-165 (1995).
37. STROHMEYER, T., PETER, S., HARTMANN, M., MUNEMITSU, S., ACKERMANN, R., ULLRICH, A. and SLAMON, D.J., Expression of the hst-1 and c-kit protooncogenes in human testicular germ cell tumors. Cancer Res., 51, 1811-1816 (1991).
38. TAKAHASHI, H. and 15 OTHERS, Mutation analysis of the BRCAI gene in ovarian cancers. Cancer Res., 55, 2998-3002 (1995).
39. WRIGLEY, E., MCGOWN, A.T., WARD, T.H., EWEN, C. and CROWTHER, D., C-kit receptors in ovarian tumors and THE RESPONSE OF OVARIAN CARCINOMA CELL LINES TO RECOMBINANT HUMAN STEM CELL FACTOR. Int. J. Gynecol. Cancer, 6, 273-278 (1996).
40. YARDEN, Y., KUANG, W.-J., YANG-FENG, T., COUSSENS, L., MUNEMITSU, S., DULL, T.J., CHEN, E., SCHLESSINGER, J., FRANCKE, U. and ULLRICH, A., Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J., 6, 3341-3351 (1987).